Liver fat can be quickly and significantly reduced with a gastrointestinal hormone

(Natural News) A study published in The Lancet reported that NGM282, a non-tumorigenic variant of a hormone found in the gastrointestinal tract, was able to reduce the liver fat content in patients with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). According to researchers, the findings demonstrated the potential of the compound to be used in treating both…

>View original article